In silico Analysis of nsSNPs in the Human ACTN4 Gene associated with a Steroid-Resistant Nephrotic Syndrome
DOI:
https://doi.org/10.37591/rrjohp.v8i3.616Abstract
The main motive of this study is to discover nsSNPs of ACTN4 gene through various insilico views. ACTN4 is one of the proteins that play a leading role in cellular pathways by altering cytoskeletal behaviour associated with steroid-resistant nephrotic syndrome. Data of ACTN4 was collected from NCBI dbSNP and Uniport KB and further used to explore adverse outcome using SIFT, PolyPhen, PROVEAN and SNAP2.Out of 11 nsSNPs selected in this study, three nsSNPs rs121908415 at position K255E, rs878853159 at position G195D, and rs1114167420 at position M240T were predicted as deleterious by SIFT, PROVEAN, PolyPhen and SNAP2. Decrease instability due to mutation was observed in these three nsSNPs through I-Mutant2.0. We modelled 3D structure using I-TASSER and stability of built structure was confirmed via Procheck to get a Ramachandran plot. There were several PTM sites identified in ACTN4 protein. This study shows that K255E, G195D and M240T variants of ACTN4 could somehow disrupt the amino acid interaction that will affect the function of the protein to some extent.
Keywords: ACTN4 gene, in silico views, steroid-resistant nephrotic syndrome, nsSNPs (Non-synonymous single nucleotide polymorphisms), PTM (Post-Translational modification)
Cite this Article
Parmar Glory S, Mistry Kinnari N, Rank Dharamshibhai N, et al. In silico Analysis of nsSNPs in the Human ACTN4 Gene associated with a Steroid-Resistant Nephrotic Syndrome. Research & Reviews: A Journal of Health Professions. 2018; 8(Issue 3 Special): 43s-52s.
Downloads
Published
Issue
Section
License
Declaration and Copyright Transfer Form
(to be completed by authors)
I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.
- I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
- I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
- I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
- I/We also agree to the authorship of the article in the following order:
Author’s name
1. ________________
2. ________________
3. ________________
4. ________________
| We Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal. |